// App-Quantinova.ai

29097 : RISKS AND BENEFITS OF POSTPROCEDURAL ANTICOAGULATION IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI: ANALYSIS FROM THE HORIZONSAMI TRIAL

Researchers

Presenter

  • Mahesh Madhavan

Principal Investigators

  • Bernhard Witzenbichler

  • Philippe Genereux

  • Martin Fahy

  • Roxana Mehran

  • Gregg Stone

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved